What Can I Take for Anxiety? A Psychiatry and Primary Care Guide

What Can I Take for Anxiety? A Psychiatry and Primary Care Guide

If you’ve ever typed “what can I take for anxiety” into a search bar, you’re not alone. Anxiety is one of the most common reasons people visit their doctor, yet the answer isn’t a single pill or a one-size-fits-all solution. The good news is that there are more safe, effective options than ever before—and an integrated psychiatry and primary care practice is uniquely positioned to help you find the right one.

At Psychiatry & Primary Care, we believe treating anxiety isn’t just about writing a prescription. It’s about understanding your anxiety, your health history, and your goals—then building a plan that fits your life.

First, a Reality Check: There’s No “One Thing” That Works for Everyone

Anxiety is not a character flaw or a sign of weakness. It’s a real medical condition influenced by genetics, brain chemistry, life experiences, and even physical health factors like sleep, diet, and thyroid function. Because anxiety shows up differently in different people—some feel constant worry, others have panic attacks, and others struggle with social situations—the “best” treatment depends on your specific symptoms and circumstances.

That said, the research is clear on where to start.

Therapy Is a First-Line Treatment—Not a Last Resort

Before we talk about medications, it’s important to know that cognitive-behavioral therapy (CBT) is considered a first-line treatment for anxiety disorders. In fact, studies show that 10–15 sessions of CBT can significantly reduce anxiety severity, with benefits lasting for months after treatment ends.

The advantage of an integrated psychiatry and primary care practice is that we can connect you with behavioral health support within the same care team. You don’t have to navigate a fragmented system or wait months for a separate referral. For many people, therapy alone is enough. For others, therapy plus medication offers the best results.

Medication Options: What You Can “Take” for Anxiety

If medication is part of your plan, here are the main categories your provider may discuss with you.

First-Line: SSRIs and SNRIs

Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are the most commonly prescribed first-line medications for anxiety disorders. They work by regulating neurotransmitters in the brain that affect mood and fear responses.

  • Common SSRIs for anxiety: sertraline (Zoloft), escitalopram (Lexapro), paroxetine (Paxil), and fluoxetine (Prozac).
  • Common SNRIs for anxiety: venlafaxine (Effexor XR) and duloxetine (Cymbalta).

These medications are not addictive in the way benzodiazepines are, but they take time—typically 4–8 weeks—to reach full effect. They work best when taken consistently, not “as needed.” Your provider will monitor side effects and adjust the dose carefully over time.

Non-Addictive Alternatives: Buspirone and Hydroxyzine

Not everyone responds to or tolerates SSRIs/SNRIs. Fortunately, there are other non-addictive options.

  • Buspirone (Buspar) is FDA-approved specifically for generalized anxiety disorder. It works differently from antidepressants, has no addiction risk, and doesn’t cause sedation or cognitive impairment. However, it takes 2–4 weeks to work and is not effective for acute anxiety episodes.
  • Hydroxyzine (Vistaril, Atarax) is an antihistamine with anti-anxiety properties. It works relatively quickly (within 30–60 minutes) and carries no addiction risk, making it useful for short-term relief while waiting for a daily medication to kick in. The trade-off is that it can cause drowsiness.

Beta-Blockers for Physical Symptoms

Beta-blockers like propranolol are not anxiety medications in the traditional sense, but they can be very effective for the physical symptoms of anxiety—racing heart, trembling, sweating—especially in performance or social anxiety situations. They block adrenaline’s effects on the body without acting directly on the brain’s anxiety centers.

Benzodiazepines: Cautious, Short-Term Use Only

Benzodiazepines (e.g., alprazolam/Xanax, lorazepam/Ativan, clonazepam/Klonopin) are fast-acting and can provide rapid relief during severe anxiety flare-ups. However, they carry risks of tolerance, dependence, and withdrawal with long-term use. Current guidelines strongly caution against routine long-term benzodiazepine prescribing for anxiety. When they are used, they should be prescribed cautiously, for limited durations, under close medical supervision.

What About Natural Remedies and Supplements?

Many people want to explore over-the-counter options first. While there are no FDA-approved OTC medications for anxiety disorders, some supplements and lifestyle strategies have evidence behind them.

Supplements with some supportive evidence:

  • Magnesium: Supports nervous system regulation and GABA activity; most adults need 310–420 mg daily.
  • Vitamin B-6: Needed to produce serotonin, dopamine, and GABA; high-dose supplementation has shown promise, but too much can cause nerve damage, so dosing matters.
  • L-theanine: An amino acid found in tea that may promote relaxation by enhancing GABA and alpha brain waves; may be most helpful for people with higher baseline anxiety.
  • Omega-3 fatty acids: Found in fish and some plant sources; a Mediterranean-style diet plus omega-3 supplementation has shown benefit for anxiety symptoms.

Herbal options (use with caution): Chamomile, passionflower, lemon balm, valerian root, and ashwagandha are commonly used, but evidence varies, and some—like kava—carry liver risks. Always talk to your provider before starting any supplement, especially if you take other medications.

Lifestyle foundations: Regular physical activity, consistent sleep, limiting caffeine and alcohol, eating balanced meals with protein and complex carbohydrates, and staying hydrated all play a meaningful role in anxiety management.

Why an Integrated Psychiatry and Primary Care Approach Makes a Difference

Anxiety rarely exists in isolation. It can worsen chronic health conditions, disrupt sleep, affect work and relationships, and be confused with or worsened by medical issues like thyroid problems or cardiac conditions.

The Collaborative Care Model—where primary care clinicians, consulting psychiatrists, and care managers work together—has been shown to improve anxiety outcomes compared to usual care. In an integrated practice like Psychiatry & Primary Care, you get:

  • One coordinated team that looks at the whole picture: your mental health, your physical health, and your lifestyle.
  • Faster access to the right treatment, whether that’s therapy, medication, or both.
  • Ongoing monitoring and adjustment so your plan evolves as your needs change.

You don’t have to figure this out alone, and you don’t have to choose between “therapy” and “medication” in separate silos. The right answer is the one that’s tailored to you.

The Bottom Line

So, what can you take for anxiety? The honest answer is: it depends—but there are many effective paths forward. Therapy, SSRIs/SNRIs, non-addictive alternatives like buspirone or hydroxyzine, targeted beta-blockers, and evidence-informed lifestyle changes all have a place. The key is working with a provider who will listen, assess thoroughly, and build a plan with you—not just hand you a prescription.

If anxiety is interfering with your life, you deserve more than a quick search result. Reach out to Psychiatry & Primary Care today to schedule a comprehensive evaluation. Together, we’ll find the approach that helps you feel like yourself again.

The sources below include systematic reviews, meta-analyses, randomized controlled trials, and clinical practice guidelines. Individual treatment decisions should always be made with a qualified clinician

References

Cognitive Behavioral Therapy (CBT) as a First-Line Treatment

National Institute for Health and Care Excellence. (2011). Generalised anxiety disorder and panic disorder in adults: Management (NICE Clinical Guideline CG113). https://www.nice.org.uk/guidance/cg113

Probst, G. H., Gómez Penedo, J. M., & Flückiger, C. (2025). Long-term efficacy of cognitive behavioural therapy for generalized anxiety disorder: A 2–8-year follow-up of two randomized controlled trials. Behaviour Research and Therapy, 191, Article 104758. https://doi.org/10.1016/j.brat.2025.104758

SSRIs and SNRIs as First-Line Pharmacotherapy

Kopcalic, K., Arcaro, J., Pinto, A., Ali, S., Barbui, C., Curatoli, C., Martin, J., & Guaiana, G. (2025). Antidepressants versus placebo for generalised anxiety disorder (GAD). Cochrane Database of Systematic Reviews, 2025(1), Article CD012942. https://doi.org/10.1002/14651858.CD012942.pub2

Buspirone for Generalized Anxiety Disorder

Gammans, R. E., Stringfellow, J. C., Hvizdos, A. J., Seidehamel, R. J., Cohn, J. B., Wilcox, C. S., Fabre, L. F., Pecknold, J. C., Smith, W. T., & Rickels, K. (1992). Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms: A meta-analysis of eight randomized, controlled studies. Neuropsychobiology, 25(4), 193–201. https://doi.org/10.1159/000118837

Hydroxyzine for Short-Term Anxiety Relief

Guaiana, G., Barbui, C., & Cipriani, A. (2010). Hydroxyzine for generalised anxiety disorder. Cochrane Database of Systematic Reviews, 2010(12), Article CD006815. https://doi.org/10.1002/14651858.CD006815.pub2

Beta-Blockers and Performance Anxiety

Brantigan, C. O., Brantigan, T. A., & Joseph, N. (1982). Effect of beta blockade and beta stimulation on stage fright. The American Journal of Medicine, 72(1), 88–94. https://doi.org/10.1016/0002-9343(82)90592-7

Note: This is an older but frequently cited controlled trial. More recent reviews have reached mixed conclusions about routine propranolol use for anxiety disorders broadly; the evidence is strongest for performance-specific physical symptoms.

Benzodiazepine Risks and Cautious Use

Brunner, E., Chen, C.-Y. A., Klein, T., Maust, D., Mazer-Amirshahi, M., Mecca, M., Najera, D., Ogbonna, C., Rajneesh, K. F., Roll, E. A., Sanders, A. E., Snodgrass, B., VandenBerg, A., Wright, T., Boyle, M., Devoto, A., Framnes-DeBoer, S., Kleykamp, B., Norrington, J., & Lindsay, D. (2025). Joint clinical practice guideline on benzodiazepine tapering: Considerations when risks outweigh benefits. Journal of General Internal Medicine, 40(12), 2814–2859. https://doi.org/10.1007/s11606-025-09499-2

Magnesium Supplementation

Boyle, N. B., Lawton, C., & Dye, L. (2017). The effects of magnesium supplementation on subjective anxiety and stress—A systematic review. Nutrients, 9(5), Article 429. https://doi.org/10.3390/nu9050429

L-Theanine Supplementation

Williams, J. L., Everett, J. M., D’Cunha, N. M., Sergi, D., Georgousopoulou, E. N., Keegan, R. J., McKune, A. J., & Naumovski, N. (2020). The effects of green tea amino acid L-theanine consumption on the ability to manage stress and anxiety levels: A systematic review. Plant Foods for Human Nutrition, 75(1), 12–23. https://doi.org/10.1007/s11130-019-00771-5

Omega-3 Fatty Acids

Bafkar, N., Zeraattalab-Motlagh, S., Jayedi, A., & Shab-Bidar, S. (2024). Efficacy and safety of omega-3 fatty acids supplementation for anxiety symptoms: A systematic review and dose-response meta-analysis of randomized controlled trials. BMC Psychiatry, 24(1), Article 455. https://doi.org/10.1186/s12888-024-05881-2

Vitamin B6: Mixed Evidence

Field, D. T., Cracknell, R. O., Eastwood, J. R., Scarfe, P., Williams, C. M., Zheng, Y., & Tavassoli, T. (2022). High-dose vitamin B6 supplementation reduces anxiety and strengthens visual surround suppression. Human Psychopharmacology: Clinical and Experimental, 37(6), Article e2852. https://doi.org/10.1002/hup.2852

Noah, L., Dye, L., Bois De Fer, B., Mazur, A., Pickering, G., & Pouteau, E. (2021). Effect of magnesium and vitamin B6 supplementation on mental health and quality of life in stressed healthy adults: Post-hoc analysis of a randomised controlled trial. Stress and Health, 37(5), 1000–1009. https://doi.org/10.1002/smi.3051

Note: The Field et al. trial found benefit for anxiety in some analyses, while the post-hoc analysis by Noah et al. found no significant difference between magnesium + B6 and magnesium alone. This is why the blog appropriately frames B6 evidence as “mixed.”

Collaborative Care in Primary Care

Curth, N. K., Hjorthøj, C., Brinck-Claussen, U., Jørgensen, K. B., Rosendal, S., Bojesen, A. B., Nordentoft, M., & Eplov, L. F. (2023). The effects of collaborative care versus consultation liaison for anxiety disorders and depression in Denmark: Two randomised controlled trials. The British Journal of Psychiatry, 223(3), 430–437. https://doi.org/10.1192/bjp.2023.77

Rollman, B. L., Belnap, B. H., Mazumdar, S., Abebe, K. Z., Karp, J. F., Lenze, E. J., & Schulberg, H. C. (2017). Telephone-delivered stepped collaborative care for treating anxiety in primary care: A randomized controlled trial. Journal of General Internal Medicine, 32(3), 245–255. https://doi.org/10.1007/s11606-016-3873-1

Rollman, B. L., Herbeck Belnap, B., Abebe, K. Z., Spring, M. B., Rotondi, A. J., Rothenberger, S. D., & Karp, J. F. (2018). Effectiveness of online collaborative care for treating mood and anxiety disorders in primary care: A randomized clinical trial. JAMA Psychiatry, 75(1), 56–64. https://doi.org/10.1001/jamapsychiatry.2017.3379